Stock SILK SILK ROAD MEDICAL, INC
Add to a list
To use this feature you must be a member
Log inSign up

All News Silk Road Medical, Inc

Equities

SILK

US82710M1009

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/05/2024 BST 		5-day change 1st Jan Change
22.18 USD -1.20% Intraday chart for Silk Road Medical, Inc +5.47% +80.77%
05-15 Transcript : Silk Road Medical, Inc Presents at Bank of America Health Care Conference 2024, May-14-2024 through May-16-2024
04-30 Transcript : Silk Road Medical, Inc, Q1 2024 Earnings Call, Apr 30, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Silk Road Medical, Inc Presents at Bank of America Health Care Conference 2024, May-14-2024 through May-16-2024
Silk Road Medical: Q1 Earnings Snapshot
AQ
Transcript : Silk Road Medical, Inc, Q1 2024 Earnings Call, Apr 30, 2024
Earnings Flash (SILK) SILK ROAD MEDICAL Reports Q1 Revenue $48.5M, vs. Street Est of $44.7M
MT
Silk Road Medical Reports First Quarter 2024 Financial Results
GL
Silk Road Medical, Inc Provides Revenue Guidance for the Full Year 2024
CI
Silk Road Medical, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
GL
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
GL
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
GL
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuro Protection System Plus
CI
North American Morning Briefing : Stock Futures -2-
DJ
Silk Road Medical Inc. and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products
CI
Argus Upgrades Silk Road Medical to Buy From Hold, Price Target is $24
MT
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
GL
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
AQ
Silk Road Medical Expands TCAR Portfolio with Launch of Tapered Enroute®? Transcarotid Stent System
CI
Piper Sandler Raises Price Target on Silk Road Medical to $18 From $11, Maintains Neutral Rating
MT
Silk Road Medical: Q4 Earnings Snapshot
AQ
Transcript : Silk Road Medical, Inc, Q4 2023 Earnings Call, Feb 28, 2024
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SILK Stock
  4. News Silk Road Medical, Inc